All articles by Brendan Melck

Germany’s Ministry of Health refutes accusations of worsening market conditions

Germany’s Federal Ministry of Health has published its evaluation report on the impact of the GKV Financial Stabilization Act on…
The large amendment to Poland’s Reimbursement Act—disappointing, but not disastrous

The large amendment to Poland’s Reimbursement Act (Duża Nowelizacja Ustawy Refundacyjnej, DNUR) finally came into legal force on November 1,…
The Unitary Patent and the Unified Patent Court: possible opening in second half of 2022 will mean a complex European patent patchwork

A unified system of European patents has been a goal of those working towards European integration since before the establishment…
Will IRP upend Czech orphan drug reforms?

On 14 September, the Czech Chamber of Deputies gave its final approval to the amendment of the Public Health Insurance…
Germany’s ESG Law: A case study for new pharma pricing model

Pharmaceutical pricing is increasingly becoming a broader topic in the global push towards sustainability and environmental, social, and government (ESG)…

Polish pharma associations unite in appeal for greater access to biologics

Poland's pricing and reimbursement system has always had a reputation for restrictiveness when it comes to originator therapies, with its…
Germany’s fixed pricing for medicines faces European reckoning

Fixed prices for prescription medicines are an important part of the framework of pharmaceutical pricing and reimbursement regulation in Germany.…
New payment-by-results and payback regulations for Bulgaria

Earlier this year, important amendments to of Ordinance 10 (on the terms and procedure for the payment of medicinal products)…
Medical supplies to Czech hospitals to be stopped after call to reveal drug prices in tenders

The Czech Republic has become the center-ground for another battle over transparency of confidential pharmaceutical prices after health minister Adam…
Drug supply shortages in Germany

Drug supply shortages have become an increasingly pressing issue in Germany in the past 5 years, and the pharmaceutical industry…